Matches in Nanopublications for { ?s ?p "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP577338.RASBuXCdIG2JVreIzXIBnLLsp-iLcWS2VHyW-SGepvaBg130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577338.RASBuXCdIG2JVreIzXIBnLLsp-iLcWS2VHyW-SGepvaBg130_provenance.
- NP276396.RAlw1uz6ukpGPeOL0BTIGam-EPMtfZEdCi-bAXVLsgbjo130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276396.RAlw1uz6ukpGPeOL0BTIGam-EPMtfZEdCi-bAXVLsgbjo130_provenance.
- NP178513.RA_TgwjiNVCS4oECB9-YRaXHnTQDNjXg2h6pTcYmTm-Kw130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178513.RA_TgwjiNVCS4oECB9-YRaXHnTQDNjXg2h6pTcYmTm-Kw130_provenance.
- NP211993.RAzWeMY9dkd8EEsefqO4W5Wcf1Oj-V5pQHn9lbXG7N4-Q130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211993.RAzWeMY9dkd8EEsefqO4W5Wcf1Oj-V5pQHn9lbXG7N4-Q130_provenance.
- NP625912.RAsT6M9OmJT6Ljd3rOOwcA-t7UST79PHE1zRVsSbCD6ik130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625912.RAsT6M9OmJT6Ljd3rOOwcA-t7UST79PHE1zRVsSbCD6ik130_provenance.
- assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP699022.RA46JuyCT2FCuFL449zBCeSYZj0s5anxvcYwHHXyVx24w130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699022.RA46JuyCT2FCuFL449zBCeSYZj0s5anxvcYwHHXyVx24w130_provenance.
- NP699023.RA22SUSSYnmNchbMyzo2pdeLXjBPhnOnVp3Qx1V_4wihk130_assertion description "[We confirmed the usefulness of P16 immunocytochemistry combined with ISH and HPV genotyping as ancillary molecular-biological tests of LBC specimens for identifying patients at high risk of cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699023.RA22SUSSYnmNchbMyzo2pdeLXjBPhnOnVp3Qx1V_4wihk130_provenance.